Annual Operating Expenses
$78.78 M
-$7.68 M-8.88%
December 31, 2024
Summary
- As of March 13, 2025, BDTX annual total operating expenses is $78.78 million, with the most recent change of -$7.68 million (-8.88%) on December 31, 2024.
- During the last 3 years, BDTX annual operating expenses has fallen by -$48.09 million (-37.91%).
- BDTX annual operating expenses is now -37.91% below its all-time high of $126.87 million, reached on December 31, 2021.
Performance
BDTX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$18.27 M
+$145.00 K+0.80%
December 31, 2024
Summary
- As of March 13, 2025, BDTX quarterly total operating expenses is $18.27 million, with the most recent change of +$145.00 thousand (+0.80%) on December 31, 2024.
- Over the past year, BDTX quarterly operating expenses has stayed the same.
- BDTX quarterly operating expenses is now -48.32% below its all-time high of $35.36 million, reached on September 30, 2021.
Performance
BDTX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
BDTX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.9% | 0.0% |
| 3 y3 years | -37.9% | -29.9% |
| 5 y5 years | +168.6% | +76.7% |
BDTX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -37.9% | at low | -29.9% | +0.8% |
| 5 y | 5-year | -37.9% | +168.6% | -48.3% | +76.7% |
| alltime | all time | -37.9% | +1812.6% | -48.3% | +500.0% |
Black Diamond Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $78.78 M(-8.9%) | $18.27 M(+0.8%) |
| Sep 2024 | - | $18.13 M(-18.1%) |
| Jun 2024 | - | $22.13 M(+9.3%) |
| Mar 2024 | - | $20.25 M(-2.9%) |
| Dec 2023 | $86.46 M(-6.9%) | $20.86 M(-13.1%) |
| Sep 2023 | - | $24.01 M(+19.9%) |
| Jun 2023 | - | $20.03 M(-7.1%) |
| Mar 2023 | - | $21.56 M(-1.3%) |
| Dec 2022 | $92.83 M(-26.8%) | $21.85 M(-1.2%) |
| Sep 2022 | - | $22.12 M(-4.5%) |
| Jun 2022 | - | $23.17 M(-9.8%) |
| Mar 2022 | - | $25.68 M(-1.5%) |
| Dec 2021 | $126.87 M | $26.08 M(-26.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $35.36 M(+1.9%) |
| Jun 2021 | - | $34.72 M(+13.0%) |
| Mar 2021 | - | $30.71 M(+32.5%) |
| Dec 2020 | $69.57 M(+137.2%) | $23.18 M(+25.4%) |
| Sep 2020 | - | $18.48 M(+23.0%) |
| Jun 2020 | - | $15.03 M(+16.7%) |
| Mar 2020 | - | $12.88 M(+24.5%) |
| Dec 2019 | $29.33 M(+229.4%) | $10.34 M(+27.0%) |
| Sep 2019 | - | $8.15 M(+16.4%) |
| Jun 2019 | - | $7.00 M(+82.2%) |
| Mar 2019 | - | $3.84 M(+26.1%) |
| Dec 2018 | $8.90 M(+116.2%) | $3.05 M |
| Dec 2017 | $4.12 M | - |
FAQ
- What is Black Diamond Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics annual operating expenses year-on-year change?
- What is Black Diamond Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics quarterly operating expenses year-on-year change?
What is Black Diamond Therapeutics annual total operating expenses?
The current annual operating expenses of BDTX is $78.78 M
What is the all time high annual operating expenses for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high annual total operating expenses is $126.87 M
What is Black Diamond Therapeutics annual operating expenses year-on-year change?
Over the past year, BDTX annual total operating expenses has changed by -$7.68 M (-8.88%)
What is Black Diamond Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of BDTX is $18.27 M
What is the all time high quarterly operating expenses for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high quarterly total operating expenses is $35.36 M
What is Black Diamond Therapeutics quarterly operating expenses year-on-year change?
Over the past year, BDTX quarterly total operating expenses has changed by $0.00 (0.00%)